ILMN

$238.215.13%11.63

Dopo l'orario di chiusura: 238.210.00 0.00%

Illumina Inc (ILMN)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$226.58

Aprire:

$233.14

Volume 24 ore:

2,213,191

Volume relativo:

0.93

Capitalizzazione di mercato:

$36.02B

Reddito:

$4.39B

Utile/perdita netta:

$853.00M

Rapporto P/E:

43.23

EPS:

$5.51

Flusso di cassa netto:

$556.00M

1W Prestazione:

-14.76%

1M Prestazione:

-12.76%

6M Prestazione:

+75.44%

1Y Prestazione:

+98.52%

Intervallo 1D:

$229.08$241.85

Intervallo di 1 settimana:

$223.33$294.21

Portata 52W:

$112.65$309.35

Profilo aziendale di Illumina Inc (ILMN)

Nome

Illumina Inc

Settore

Healthcare

Industria

Diagnostics & Research

Telefono

(858) 202-4500

Indirizzo

5200 ILLUMINA WAY, SAN DIEGO, CA, USA

Dipendente

8,600

@illumina

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di ILMN su X

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Illumina Inc Azioni (ILMN) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-10-23	Downgrade	Stephens	Overweight → Equal-Weight
2026-09-09	Resumed	UBS	Buy
2026-06-26	Resumed	Bernstein	Mkt Perform
2026-06-10	Aggiornamento	JP Morgan	Neutral → Overweight
2026-05-15	Resumed	RBC Capital Mkts	Outperform
2026-05-14	Aggiornamento	Daiwa Securities	Neutral → Outperform
2025-08-12	Downgrade	Daiwa Securities	Outperform → Neutral
2025-07-11	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2025-03-04	Reiterato	Citigroup	Neutral
2025-02-28	Downgrade	HSBC Securities	Buy → Hold
2025-02-10	Downgrade	Barclays	Equal Weight → Underweight
2025-02-07	Downgrade	TD Cowen	Buy → Hold
2024-12-11	Downgrade	Citigroup	Buy → Neutral
2024-11-12	Resumed	Morgan Stanley	Equal-Weight
2024-10-17	Aggiornamento	HSBC Securities	Hold → Buy
2024-08-28	Aggiornamento	Argus	Hold → Buy
2024-08-16	Aggiornamento	Daiwa Securities	Neutral → Buy
2024-08-14	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-14	Aggiornamento	TD Cowen	Hold → Buy
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-03	Resumed	Jefferies	Hold
2024-01-16	Downgrade	HSBC Securities	Buy → Hold
2024-01-04	Downgrade	TD Cowen	Outperform → Market Perform
2023-12-18	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2023-12-15	Aggiornamento	Bernstein	Underperform → Mkt Perform
2023-12-14	Iniziato	Guggenheim	Buy
2023-12-14	Iniziato	Stephens	Overweight
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Neutral → Underperform
2023-12-11	Aggiornamento	Citigroup	Sell → Neutral
2023-11-10	Downgrade	Canaccord Genuity	Buy → Hold
2023-09-28	Iniziato	Bernstein	Underperform
2023-07-05	Resumed	JP Morgan	Neutral
2023-01-25	Downgrade	Argus	Buy → Hold
2023-01-05	Iniziato	Scotiabank	Sector Perform
2022-12-12	Downgrade	Citigroup	Neutral → Sell
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-10-04	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-09-28	Aggiornamento	Evercore ISI	In-line → Outperform
2022-08-25	Iniziato	Credit Suisse	Neutral
2022-07-13	Downgrade	Barclays	Equal Weight → Underweight
2022-01-18	Aggiornamento	Stifel	Hold → Buy
2022-01-11	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-07	Aggiornamento	BofA Securities	Underperform → Neutral
2022-01-06	Resumed	Morgan Stanley	Equal-Weight
2022-01-06	Resumed	Piper Sandler	Overweight
2021-10-15	Resumed	Cowen	Outperform
2021-08-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-06-01	Aggiornamento	Evercore ISI	Underperform → In-line
2021-03-31	Downgrade	Atlantic Equities	Overweight → Neutral
2021-03-31	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-03-03	Iniziato	Barclays	Underweight
2020-12-22	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-12-17	Aggiornamento	BTIG Research	Neutral → Buy
2020-10-13	Downgrade	Guggenheim	Buy → Neutral
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-09-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-09-22	Downgrade	Stifel	Buy → Hold
2020-09-22	Downgrade	UBS	Buy → Neutral
2020-09-21	Aggiornamento	Guggenheim	Neutral → Buy
2020-09-21	Downgrade	JP Morgan	Overweight → Neutral
2020-09-09	Iniziato	Morgan Stanley	Equal-Weight
2020-08-07	Downgrade	Evercore ISI	In-line → Underperform
2020-08-07	Downgrade	Piper Sandler	Overweight → Neutral
2020-07-07	Downgrade	Guggenheim	Buy → Neutral
2020-04-24	Downgrade	Citigroup	Buy → Neutral
2020-04-21	Downgrade	Robert W. Baird	Outperform → Neutral
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Iniziato	Citigroup	Buy
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-11-15	Iniziato	Stifel	Buy
2019-10-25	Iniziato	Guggenheim	Buy

Illumina Inc Azioni (ILMN) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-28	2024-12-29	2023-12-31	2023-01-01	2021-01-03
Revenue USD (M)	4,343.00	4,372.00	4,504.00	4,526.00	4,526.00
Cost of revenue USD (M)	1,473.00	1,511.00	1,760.00	1,372.00	1,372.00
Gross profit USD (M)	2,870.00	2,861.00	2,744.00	3,154.00	3,154.00
Research and development USD (M)	967.00	1,169.00	1,354.00	1,185.00	1,185.00
Operating expenses USD (M)	2,063.00	3,694.00	3,813.00	3,277.00	3,277.00
Operating income USD (M)	807.00	-833.00	-1,069.00	-123.00	-123.00
Income before tax USD (M)	1,086.00	-1,179.00	-1,117.00	884.00	884.00
Income tax expense USD (M)	236.00	44.00	44.00	122.00	122.00
Net income USD (M)	850.00	-1,223.00	-1,161.00	762.00	762.00
Basic EPS USD/shares	5.47	-7.69	-7.34	5.07	5.07
Diluted EPS USD/shares	5.45	-7.69	-7.34	5.04	5.04
Basic weighted shares shares (M)	155.00	159.00	158.00	150.00	150.00
Diluted weighted shares shares (M)	156.00	159.00	158.00	151.00	151.00
Selling, general and administrative USD (M)	1,086.00	1,092.00	1,612.00	2,092.00	2,092.00

Illumina Inc Azioni (ILMN) insider trading

Corvex Management LPNov 03 '26
Affiliate of Director (1)
Transazione
Proposed Sale
Costo
$235.99
#Azioni
369,501
Valore ($)
87,198,541
#Azioni Totale
0
Meister Keith A.Sep 04 '26
Director
Transazione
Sale
Costo
$218.40
#Azioni
119,501
Valore ($)
26,098,466
#Azioni Totale
770,350
Corvex Management LPSep 04 '26
Affiliate of Director (1)
Transazione
Proposed Sale
Costo
$213.25
#Azioni
150,000
Valore ($)
31,987,500
#Azioni Totale
0
Meister Keith A.Sep 03 '26
Director
Transazione
Sale
Costo
$218.23
#Azioni
75,951
Valore ($)
16,574,481
#Azioni Totale
889,851
Meister Keith A.Sep 02 '26
Director
Transazione
Sale
Costo
$213.28
#Azioni
68,108
Valore ($)
14,526,254
#Azioni Totale
965,802
Corvex Management LPAug 27 '26
Affiliate of Director (1)
Transazione
Proposed Sale
Costo
$224.84
#Azioni
200,000
Valore ($)
44,968,000
#Azioni Totale
0
Meister Keith A.Aug 27 '26
Director
Transazione
Sale
Costo
$228.89
#Azioni
138,379
Valore ($)
31,673,778
#Azioni Totale
1,033,910
Meister Keith A.Aug 26 '26
Director
Transazione
Sale
Costo
$225.46
#Azioni
106,543
Valore ($)
24,021,247
#Azioni Totale
1,172,289
Corvex Management LPAug 25 '26
Affiliate of Director (1)
Transazione
Proposed Sale
Costo
$223.22
#Azioni
300,000
Valore ($)
66,966,000
#Azioni Totale
0
Meister Keith A.Aug 25 '26
Director
Transazione
Sale
Costo
$225.51
#Azioni
131,019
Valore ($)
29,546,639
#Azioni Totale
1,278,832

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Corvex Management LP	Affiliate of Director (1)	Nov 03 '26	Proposed Sale	$235.99	369,501	87,198,541	0
Meister Keith A.	Director	Sep 04 '26	Sale	$218.40	119,501	26,098,466	770,350
Corvex Management LP	Affiliate of Director (1)	Sep 04 '26	Proposed Sale	$213.25	150,000	31,987,500	0
Meister Keith A.	Director	Sep 03 '26	Sale	$218.23	75,951	16,574,481	889,851
Meister Keith A.	Director	Sep 02 '26	Sale	$213.28	68,108	14,526,254	965,802
Corvex Management LP	Affiliate of Director (1)	Aug 27 '26	Proposed Sale	$224.84	200,000	44,968,000	0
Meister Keith A.	Director	Aug 27 '26	Sale	$228.89	138,379	31,673,778	1,033,910
Meister Keith A.	Director	Aug 26 '26	Sale	$225.46	106,543	24,021,247	1,172,289
Corvex Management LP	Affiliate of Director (1)	Aug 25 '26	Proposed Sale	$223.22	300,000	66,966,000	0
Meister Keith A.	Director	Aug 25 '26	Sale	$225.51	131,019	29,546,639	1,278,832

Illumina Inc Borsa (ILMN) Ultime notizie

Nov 02, 2026

3 Stocks to Watch Following Guidance Upgrades - Zacks Investment Research

Nov 02, 2026

Why Illumina (ILMN) is a Top Growth Stock for the Long-Term - Zacks Investment Research

Nov 02, 2026

Oct 30, 2026

3 Promising Genomics Stocks to Add to Your Portfolio Now - Zacks Investment Research

Oct 30, 2026

ILMN Q3 Earnings Call Highlights Higher Guidance and Clinical Growth - Zacks Investment Research

Oct 30, 2026

Why is Illumina stock tumbling today? - Investing.com

Oct 30, 2026

Oct 29, 2026